‘A Randomised Trial of the Effect and Cost-Effectiveness of Early Intensive Mulitfactorial Therapy on 5-Year Cardiovascular Outcomes in Individuals with Screen-Detected Type 2 Diaberes:The Anglod-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe) Study.’ <http://www.journalslibrary.nihr.ac.uk/hta/volume-20/issue-64#abstract>
Amori RE, Lau J and Pittas AG, ‘Efficacy and Safety of Incretin Therapy in Type 2 Diabetes’ (2007) 298 JAMA <https://doi.org/10.1001/jama.298.2.194>
Amy Kennedy, ‘Does Exercise Improve Glycaemic Control in Type 1 Diabetes? A Systematic Review and Meta-Analysis’ (2013) 8 PLoS ONE <https://doi.org/doi: 10.1371/journal.pone.0058861>
Anthony H. Barnett, Jenny Grice, New Mechanisms in Glucose Control (BMJ Books; 1 edition 2013) <http://ezproxy.lib.le.ac.uk/login?url=http://lib.myilibrary.com?id=478133>
‘[ARCHIVED CONTENT] Medicines Management: Everybody’s Business : Department of Health - Publications and Statistics’ <http://webarchive.nationalarchives.gov.uk/20080205132320/http:/dh.gov.uk/en/publicationsandstatistics/publications/publicationspolicyandguidance/dh_082200>
Atkinson MA, ‘The Pathogenesis and Natural History of Type 1 Diabetes’ (2012) 2 Cold Spring Harbor Perspectives in Medicine a007641 <https://doi.org/10.1101/cshperspect.a007641>
Avery L and others, ‘Changing Physical Activity Behavior in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Behavioral Interventions’ (2012) 35 Diabetes Care 2681 <https://doi.org/10.2337/dc11-2452>
Bailey CJ and others, ‘Effect of Dapagliflozin in Patients with Type 2 Diabetes Who Have Inadequate Glycaemic Control with Metformin: A Randomised, Double-Blind, Placebo-Controlled Trial’ (2010) 375 The Lancet 2223 <https://doi.org/10.1016/S0140-6736(10)60407-2>
Bailey, Stephen, Academic Writing : A Handbook for International Students <http://lib.myilibrary.com.ezproxy4.lib.le.ac.uk/Open.aspx?id=310467>
Barry VW and others, ‘Fitness vs. Fatness on All-Cause Mortality: A Meta-Analysis’ (2014) 56 Progress in Cardiovascular Diseases 382 <https://doi.org/10.1016/j.pcad.2013.09.002>
Bennett WL and others, ‘Comparative Effectiveness and Safety of Medications for Type 2 Diabetes: An Update Including New Drugs and 2-Drug Combinations’ (2011) 154 Annals of Internal Medicine <https://doi.org/10.7326/0003-4819-154-9-201105030-00336>
Bergenstal RM and others, ‘Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes’ (2010) 363 New England Journal of Medicine 311 <https://doi.org/10.1056/NEJMoa1002853>
Bethel MA and others, ‘Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)’ (2017) 40 Diabetes Care 494 <https://doi.org/10.2337/dc16-1135>
Beverley M Shields, ‘Can Clinical Features Be Used to Differentiate Type 1 from Type 2 Diabetes? A Systematic Review of the Literature’ (2015) 5 BMJ Open <https://doi.org/doi: 10.1136/bmjopen-2015-009088>
Birkeland KI, ‘Hyperglycaemia in Pregnancy: Still a Lot to Learn’ (2015) 3 The Lancet Diabetes & Endocrinology 752 <https://doi.org/10.1016/S2213-8587(15)00282-X>
Brown J and others, ‘Lifestyle Interventions for the Treatment of Women with Gestational Diabetes’ Cochrane Database of Systematic Reviews (John Wiley & Sons, Ltd 1996) <https://doi.org/10.1002/14651858.CD011970.pub2>
Buse JB and others, ‘Liraglutide Once a Day versus Exenatide Twice a Day for Type 2 Diabetes: A 26-Week Randomised, Parallel-Group, Multinational, Open-Label Trial (LEAD-6)’ (2009) 374 The Lancet 39 <https://doi.org/10.1016/S0140-6736(09)60659-0>
Buse JB and others, ‘DURATION-1: Exenatide Once Weekly Produces Sustained Glycemic Control and Weight Loss Over 52 Weeks’ (2010) 33 Diabetes Care 1255 <https://doi.org/10.2337/dc09-1914>
Buse JB and others, ‘Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes’ (2011) 154 Annals of Internal Medicine <https://doi.org/10.7326/0003-4819-154-2-201101180-00300>
‘Canagliflozin, Dapagliflozin and Empagliflozin as Monotherapies for Treating Type 2 Diabetes | 1-Recommendations | Guidance and Guidelines | NICE’ <https://www.nice.org.uk/guidance/ta390/chapter/1-Recommendations>
Capehorn M and others, ‘Challenges Faced by Physicians When Discussing the Type 2 Diabetes Diagnosis with Patients: Insights from a Cross-National Study (IntroDia )’ [2017] Diabetic Medicine <https://doi.org/10.1111/dme.13357>
Chimen M and others, ‘What Are the Health Benefits of Physical Activity in Type 1 Diabetes Mellitus? A Literature Review’ (2012) 55 Diabetologia 542 <https://doi.org/10.1007/s00125-011-2403-2>
Choudhary P and others, ‘Islet Cell Transplantation: Current Status in the UK (2012)’ (2012) 29 Practical Diabetes 280 <https://doi.org/10.1002/pdi.1707>
‘Constructs of Depression and Distress in Diabetes: Time for an Appraisal- ClinicalKey’ <https://www-clinicalkey-com.ezproxy3.lib.le.ac.uk/#!/content/journal/1-s2.0-S2213858715001357>
‘Continuous Subcutaneous Insulin Infusion for the Treatment of Diabetes Mellitus (Review) TA151, July 2008’ <http://www.nice.org.uk/guidance/ta151>
Copeland KC and others, ‘Management of Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) in Children and Adolescents’ (2013) 131 PEDIATRICS 364 <https://doi.org/10.1542/peds.2012-3494>
Courtney H and others, ‘Long-Term Management of Type 2 Diabetes with Glucagon-like Peptide-1 Receptor Agonists’ (2017) Volume 10 Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 79 <https://doi.org/10.2147/DMSO.S126763>
Creme P and Lea MR, Writing At University: A Guide For Students (3rd ed, McGraw-Hill Education 2008) <https://ebookcentral.proquest.com/lib/leicester/detail.action?pq-origsite=primo&docID=345134>
‘Dapagliflozin in Combination Therapy for Treating Type 2 Diabetes June 2013’ <http://www.nice.org.uk/guidance/ta288>
Davies M and others, ‘Introduction of Biosimilar Insulins in Europe’ (2017) 34 Diabetic Medicine 1340 <https://doi.org/10.1111/dme.13400>
Davies MJ and others, ‘Effectiveness of the Diabetes Education and Self Management for Ongoing and Newly Diagnosed (DESMOND) Programme for People with Newly Diagnosed Type 2 Diabetes: Cluster Randomised Controlled Trial’ (2008) 336 BMJ 491 <https://doi.org/10.1136/bmj.39474.922025.BE>
Dhatariya KK, Skedgel C and Fordham R, ‘The Cost of Treating Diabetic Ketoacidosis in the UK: A National Survey of Hospital Resource Use’ (2017) 34 Diabetic Medicine 1361 <https://doi.org/10.1111/dme.13427>
‘Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal Period (NG3’ <https://www.nice.org.uk/guidance/ng3>
‘Diagnosis and Management of Type 1 Diabetes in Children, Young People and Adults | Guidance and Guidelines | NICE’ <https://www.nice.org.uk/guidance/cg15>
Diamant M and others, ‘Once Weekly Exenatide Compared with Insulin Glargine Titrated to Target in Patients with Type 2 Diabetes (DURATION-3): An Open-Label Randomised Trial’ (2010) 375 The Lancet 2234 <https://doi.org/10.1016/S0140-6736(10)60406-0>
Dungan KM and others, ‘Once-Weekly Dulaglutide versus Once-Daily Liraglutide in Metformin-Treated Patients with Type 2 Diabetes (AWARD-6): A Randomised, Open-Label, Phase 3, Non-Inferiority Trial’ (2014) 384 The Lancet 1349 <https://doi.org/10.1016/S0140-6736(14)60976-4>
‘Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists in Type 2 Diabetes Systematic Review and Mixed-Treatment Comparison Analysis’ <http://onlinelibrary.wiley.com.ezproxy3.lib.le.ac.uk/doi/10.1111/dom.12849/epdf>
‘Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes’ (2016) 375 New England Journal of Medicine 1799 <https://doi.org/10.1056/NEJMc1611290>
‘Exenatide Prolonged-Release Suspension for Injection in Combination with Oral Antidiabetic Therapy for the Treatment of Type 2 Diabetes | Guidance and Guidelines TA 248 Feb 2015’ <https://www.nice.org.uk/guidance/ta248>
‘Exercise and Glucose Metabolism in Persons with Diabetes Mellitus: Perspectives on the Role for Continuous Glucose Monitoring’ 3 Journal of diabetes science and technology (Online) <http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769951/>
Fagin JA and Wells SA, ‘Biologic and Clinical Perspectives on Thyroid Cancer’ (2016) 375 New England Journal of Medicine 1054 <https://doi.org/10.1056/NEJMra1501993>
Ferrari M, Dal Cin M and Steele M, ‘Self-Compassion Is Associated with Optimum Self-Care Behaviour, Medical Outcomes and Psychological Well-Being in a Cross-Sectional Sample of Adults with Diabetes’ (2017) 34 Diabetic Medicine 1546 <https://doi.org/10.1111/dme.13451>
Gale EA, ‘Is Type 2 Diabetes a Category Error?’ (2013) 381 The Lancet 1956 <https://doi.org/10.1016/S0140-6736(12)62207-7>
Gallwitz B and others, ‘2-Year Efficacy and Safety of Linagliptin Compared with Glimepiride in Patients with Type 2 Diabetes Inadequately Controlled on Metformin: A Randomised, Double-Blind, Non-Inferiority Trial’ (2012) 380 The Lancet 475 <https://doi.org/10.1016/S0140-6736(12)60691-6>
Grammes J and others, ‘Focus Group Study to Identify the Central Facets of Fear of Hypoglycaemia in People with Type 2 Diabetes Mellitus’ [2017] Diabetic Medicine <https://doi.org/10.1111/dme.13506>
Gray LJ and others, ‘Implementation of the Automated Leicester Practice Risk Score in Two Diabetes Prevention Trials Provides a High Yield of People with Abnormal Glucose Tolerance’ (2012) 55 Diabetologia 3238 <https://doi.org/10.1007/s00125-012-2725-8>
Gray LJ and others, ‘External Validation of Two Diabetes Risk Scores in a Young UK South Asian Population’ (2014) 104 Diabetes Research and Clinical Practice 451 <https://doi.org/10.1016/j.diabres.2014.03.018>
Green JB and others, ‘Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes’ (2015) 373 New England Journal of Medicine 232 <https://doi.org/10.1056/NEJMoa1501352>
Gregg EW, ‘The Changing Tides of the Type 2 Diabetes Epidemic—Smooth Sailing or Troubled Waters Ahead? Kelly West Award Lecture 2016’ [2017] Diabetes Care <https://doi.org/10.2337/dci16-0055>
‘Guidelines’ <https://www.idf.org/e-library/guidelines/79-global-guideline-for-type-2-diabetes>
Hadjiconstantinou M and others, ‘Do Web-Based Interventions Improve Well-Being in Type 2 Diabetes? A Systematic Review and Meta-Analysis’ (2016) 18 Journal of Medical Internet Research <https://doi.org/10.2196/jmir.5991>
Harman-Boehm I, ‘Continuous Glucose Monitoring in Type 2 Diabetes’ (2008) 82 Diabetes Research and Clinical Practice S118 <https://doi.org/10.1016/j.diabres.2008.09.051>
Hartman YAW and others, ‘Insulin-Associated Weight Gain in Type 2 Diabetes Is Associated With Increases in Sedentary Behavior’ (2017) 40 Diabetes Care e120 <https://doi.org/10.2337/dc17-0787>
Heinonen I and others, ‘Sedentary Behaviours and Obesity in Adults: The Cardiovascular Risk in Young Finns Study’ (2013) 3 BMJ Open <https://doi.org/10.1136/bmjopen-2013-002901>
Henson, Joseph, ‘Associations of Sedentary Time with Fat Distribution in a High-Risk Population.’ <https://lra.le.ac.uk/handle/2381/32505>
Hessler DM and others, ‘Diabetes Distress Is Linked with Worsening Diabetes Management over Time in Adults with Type 1 Diabetes’ (2017) 34 Diabetic Medicine 1228 <https://doi.org/10.1111/dme.13381>
Holt RIG, Textbook of Diabetes (4th ed, Wiley-Blackwell 2010) <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>
——, Textbook of Diabetes (4th ed, Wiley-Blackwell 2010) <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>
——, Textbook of Diabetes (4th ed, Wiley-Blackwell 2010) <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>
——, Textbook of Diabetes (4th ed, Wiley-Blackwell 2010) <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>
——, Textbook of Diabetes (4th ed, Wiley-Blackwell 2010) <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>
——, Textbook of Diabetes (4th ed, Wiley-Blackwell 2010) <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>
——, Textbook of Diabetes (4th ed, Wiley-Blackwell 2010) <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>
——, Textbook of Diabetes (4th ed, Wiley-Blackwell 2010) <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>
——, Textbook of Diabetes (4th ed, Wiley-Blackwell 2010) <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>
——, Textbook of Diabetes (4th ed, Wiley-Blackwell 2010) <http://ezproxy.lib.le.ac.uk/login?url=http://www.myilibrary.com?id=269077>
——, Textbook of Diabetes (5th ed, John Wiley & Sons, Incorporated 2016) <http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056>
——, Textbook of Diabetes (5th ed, John Wiley & Sons, Incorporated 2016) <http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056>
——, Textbook of Diabetes (5th ed, John Wiley & Sons, Incorporated 2016) <http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056>
——, Textbook of Diabetes (5th ed, John Wiley & Sons, Incorporated 2016) <http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056>
——, Textbook of Diabetes (5th ed, John Wiley & Sons, Incorporated 2016) <http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056>
——, Textbook of Diabetes (5th ed, John Wiley & Sons, Incorporated 2016) <http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056>
——, Textbook of Diabetes (5th ed, John Wiley & Sons, Incorporated 2016) <http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056>
——, Textbook of Diabetes (5th ed, John Wiley & Sons, Incorporated 2016) <http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056>
——, Textbook of Diabetes (5th ed, John Wiley & Sons, Incorporated 2016) <http://ebookcentral.proquest.com/lib/leicester/detail.action?docID=4769056>
Inzucchi SE and others, ‘Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes’ (2015) 38 Diabetes Care 140 <https://doi.org/10.2337/dc14-2441>
Jelinek HF and others, ‘Data Analytics Identify Glycated Haemoglobin Co-Markers for Type 2 Diabetes Mellitus Diagnosis’ (2016) 75 Computers in Biology and Medicine 90 <https://doi.org/10.1016/j.compbiomed.2016.05.005>
John M Jakicic, ‘Physical Activity Considerations for the Treatment and Prevention of Obesity’ (2005) 82 The American Journal of Clinical Nutrition 226S <http://ajcn.nutrition.org/content/82/1/226S>
Johnston BC and others, ‘Comparison of Weight Loss Among Named Diet Programs in Overweight and Obese Adults’ (2014) 312 JAMA <https://doi.org/10.1001/jama.2014.10397>
Jones AG and Hattersley AT, ‘The Clinical Utility of C-Peptide Measurement in the Care of Patients with Diabetes’ (2013) 30 Diabetic Medicine 803 <https://doi.org/10.1111/dme.12159>
Kamlesh Khunti, ‘Systematic Review and Meta-Analysis of Response Rates and Diagnostic Yield of Screening for Type 2 Diabetes and Those at High Risk of Diabetes’ (2015) 10 PLoS ONE <https://doi.org/doi: 10.1371/journal.pone.0135702>
Kenneth Hodson, ‘Gestational Diabetes: Emerging Concepts in Pathophysiology’ (2010) 3 Obstetric Medicine <https://doi.org/doi: 10.1258/om.2010.100025>
Latika Sahu, ‘Comparison of the American Diabetes Association and World Health Organization Criteria for Gestational Diabetes Mellitus and the Outcomes of Pregnancy’ (2009) 2 Obstetric Medicine <https://doi.org/doi: 10.1258/om.2009.080049>
Lee I-M, ‘Physical Activity and Weight Gain Prevention’ (2010) 303 JAMA <https://doi.org/10.1001/jama.2010.312>
Leelarathna L and others, ‘Comparison of Different Insulin Pump Makes under Routine Care Conditions in Adults with Type 1 Diabetes’ (2017) 34 Diabetic Medicine 1372 <https://doi.org/10.1111/dme.13412>
Leff DR and Heath D, ‘Surgery for Obesity in Adulthood’ (2009) 339 BMJ b3402 <https://doi.org/10.1136/bmj.b3402>
Levin PA and others, ‘Glucagon-like Peptide-1 Receptor Agonists: A Systematic Review of Comparative Effectiveness Research’ (2017) Volume 10 Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 123 <https://doi.org/10.2147/DMSO.S130834>
‘Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes’ (2016) 375 New England Journal of Medicine 1797 <https://doi.org/10.1056/NEJMc1611289>
‘Liraglutide for the Treatment of Type 2 Diabetes Mellitus. TA203, Oct 2010’ <https://www.nice.org.uk/guidance/ta203>
‘——’ <https://www.nice.org.uk/guidance/ta203>
‘Managing Older People with Type 2 Diabetes: IDF Global Guideline - International Federation on Ageing’ <https://www.ifa-fiv.org/managing-older-people-with-type-2-diabetes-idf-global-guideline/>
Marso SP and others, ‘Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes’ (2016) 375 New England Journal of Medicine 311 <https://doi.org/10.1056/NEJMoa1603827>
——, ‘Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes’ (2016) 375 New England Journal of Medicine 311 <https://doi.org/10.1056/NEJMoa1603827>
——, ‘Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes’ [2016] New England Journal of Medicine <https://doi.org/10.1056/NEJMoa1607141>
‘Medicines Adherence: Involving Patients in Decisions about Prescribed Medicines and Supporting Adherence. CG76, Jan 2009’ <https://www.nice.org.uk/guidance/cg76>
Merlin C. Thomas, ‘Systematic Literature Review of DPP-4 Inhibitors in Patients with Type 2 Diabetes Mellitus and Renal Impairment’ (2016) 7 Diabetes Therapy <https://doi.org/doi: 10.1007/s13300-016-0189-4>
Min SH and others, ‘Comparison between SGLT2 Inhibitors and DPP4 Inhibitors Added to Insulin Therapy in Type 2 Diabetes: A Systematic Review with Indirect Comparison Meta-Analysis’ (2017) 33 Diabetes/Metabolism Research and Reviews <https://doi.org/10.1002/dmrr.2818>
‘Minimizing Hypoglycemia in Diabetes: Table 1’ (2015) 38 Diabetes Care 1583 <https://doi.org/10.2337/dc15-0279>
Mishriky BM, Cummings DM and Tanenberg RJ, ‘The Efficacy and Safety of DPP4 Inhibitors Compared to Sulfonylureas as Add-on Therapy to Metformin in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis’ (2015) 109 Diabetes Research and Clinical Practice 378 <https://doi.org/10.1016/j.diabres.2015.05.025>
Moreno-Castilla C, Mauricio D and Hernandez M, ‘Role of Medical Nutrition Therapy in the Management of Gestational Diabetes Mellitus’ (2016) 16 Current Diabetes Reports <https://doi.org/10.1007/s11892-016-0717-7>
Narendran P and others, ‘Exercise to Preserve β-Cell Function in Recent-Onset Type 1 Diabetes Mellitus (EXTOD) - a Randomized Controlled Pilot Trial’ (2017) 34 Diabetic Medicine 1521 <https://doi.org/10.1111/dme.13439>
‘National Obesity Observatory’ <http://www.noo.org.uk>
Nauck M and others, ‘Efficacy and Safety of Dulaglutide Versus Sitagliptin After 52 Weeks in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-5)’ (2014) 37 Diabetes Care 2149 <https://doi.org/10.2337/dc13-2761>
Nauck MA and others, ‘Efficacy and Safety of the Dipeptidyl Peptidase-4 Inhibitor, Sitagliptin, Compared with the Sulfonylurea, Glipizide, in Patients with Type 2 Diabetes Inadequately Controlled on Metformin Alone: A Randomized, Double-Blind, Non-Inferiority Trial’ (2007) 9 Diabetes, Obesity and Metabolism 194 <https://doi.org/10.1111/j.1463-1326.2006.00704.x>
Nauck MA and Meier JJ, ‘The Incretin Effect in Healthy Individuals and Those with Type 2 Diabetes: Physiology, Pathophysiology, and Response to Therapeutic Interventions’ (2016) 4 The Lancet Diabetes & Endocrinology 525 <https://doi.org/10.1016/S2213-8587(15)00482-9>
‘NHS Evidence: An Introduction’ <http://www.solent.nhs.uk/_store/documents/nhs_evidence_guide.pdf>
Nissen SE and Wolski K, ‘Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes’ (2007) 356 New England Journal of Medicine 2457 <https://doi.org/10.1056/NEJMoa072761>
Noctor E and Dunne F, ‘Postnatal Testing Following Gestational Diabetes’ (2015) 3 The Lancet Diabetes & Endocrinology 761 <https://doi.org/10.1016/S2213-8587(15)00322-8>
Nolan CJ and others, ‘Insulin Resistance as a Physiological Defense Against Metabolic Stress: Implications for the Management of Subsets of Type 2 Diabetes’ (2015) 64 Diabetes 673 <https://doi.org/10.2337/db14-0694>
‘Obesity: Identification, Assessment and Management | Guidance and Guidelines | NICE’ <https://www.nice.org.uk/guidance/cg189>
Paul Craddy, ‘Comparative Effectiveness of Dipeptidylpeptidase-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Mixed Treatment Comparison’ (2014) 5 Diabetes Therapy <https://doi.org/doi: 10.1007/s13300-014-0061-3>
Perrin NE and others, ‘The Prevalence of Diabetes-Specific Emotional Distress in People with Type 2 Diabetes: A Systematic Review and Meta-Analysis’ (2017) 34 Diabetic Medicine 1508 <https://doi.org/10.1111/dme.13448>
Persaud SJ and Jones PM, ‘A Wake-up Call for Type 2 Diabetes?’ (2016) 375 New England Journal of Medicine 1090 <https://doi.org/10.1056/NEJMcibr1607950>
Pickup JC, ‘Insulin-Pump Therapy for Type 1 Diabetes Mellitus’ (2012) 366 New England Journal of Medicine 1616 <https://doi.org/10.1056/NEJMct1113948>
Qin L and others, ‘Does Physical Activity Modify the Risk of Obesity for Type 2 Diabetes: A Review of Epidemiological Data’ (2010) 25 European Journal of Epidemiology 5 <https://doi.org/10.1007/s10654-009-9395-y>
Rasouli B and others, ‘Serious Life Events and the Risk of Latent Autoimmune Diabetes in Adults (LADA) and Type 2 Diabetes’ (2017) 34 Diabetic Medicine 1259 <https://doi.org/10.1111/dme.13410>
Riddle MC and others, ‘Adding Once-Daily Lixisenatide for Type 2 Diabetes Inadequately Controlled by Established Basal Insulin: A 24-Week, Randomized, Placebo-Controlled Comparison (GetGoal-L)’ (2013) 36 Diabetes Care 2489 <https://doi.org/10.2337/dc12-2454>
Rinki Murphy, ‘Monogenic Diabetes and Pregnancy’ (2015) 8 Obstetric Medicine <https://doi.org/doi: 10.1177/1753495X15590713>
Rizos CV, Kei A and Elisaf MS, ‘The Current Role of Thiazolidinediones in Diabetes Management’ (2016) 90 Archives of Toxicology 1861 <https://doi.org/10.1007/s00204-016-1737-4>
Rotz ME and others, ‘Implications of Incretin-Based Therapies on Cardiovascular Disease’ (2015) 69 International Journal of Clinical Practice 531 <https://doi.org/10.1111/ijcp.12572>
Ryder B and others, ‘ABCD Position Statement on GLP-1 Based Therapies and Pancreatic Damage’ (2013) 30 Practical Diabetes 388 <https://doi.org/10.1002/pdi.1816>
S M Attard, ‘Implications of Iron Deficiency/Anemia on the Classification of Diabetes Using HbA1c’ (2015) 5 Nutrition & Diabetes <https://doi.org/doi: 10.1038/nutd.2015.16>
Sallis JF and others, ‘Progress in Physical Activity over the Olympic Quadrennium’ (2016) 388 The Lancet 1325 <https://doi.org/10.1016/S0140-6736(16)30581-5>
Samuel VT and Shulman GI, ‘Intergrating Mechanisms for Insulin Resistance: Common Threads and Missing Links’ (2012) 148 Cell 852 <https://doi.org/10.1016/j.cell.2012.02.017>
Schauer PR and others, ‘Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes’ (2012) 366 New England Journal of Medicine 1567 <https://doi.org/10.1056/NEJMoa1200225>
——, ‘Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes’ (2017) 376 New England Journal of Medicine 641 <https://doi.org/10.1056/NEJMoa1600869>
——, ‘Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes’ (2017) 376 New England Journal of Medicine 641 <https://doi.org/10.1056/NEJMoa1600869>
Schwartz SS and others, ‘The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell–Centric Classification Schema’ (2016) 39 Diabetes Care 179 <https://doi.org/10.2337/dc15-1585>
Sivasubramaniyam S, Amiel SA and Choudhary P, ‘Proportion of Daily Capillary Blood Glucose Readings Required in the Target Range for Target Glycaemic Control: Shift of Focus from Target Range to Proportion in Range’ (2017) 34 Diabetic Medicine 1456 <https://doi.org/10.1111/dme.13438>
Sjöström L and others, ‘Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery’ (2004) 351 New England Journal of Medicine 2683 <https://doi.org/10.1056/NEJMoa035622>
Srinivasan P and others, ‘Islet Cell Transplantation’ (2007) 83 Postgraduate Medical Journal 224 <https://doi.org/10.1136/pgmj.2006.053447>
‘Standards of Medical Care in Diabetes--2015: Summary of Revisions’ (2015) 38 Diabetes Care S4 <https://doi.org/10.2337/dc15-S003>
Steven S and others, ‘Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders’ (2016) 39 Diabetes Care 808 <https://doi.org/10.2337/dc15-1942>
Steven S and Taylor R, ‘Restoring Normoglycaemia by Use of a Very Low Calorie Diet in Long- and Short-Duration Type 2 Diabetes’ (2015) 32 Diabetic Medicine 1149 <https://doi.org/10.1111/dme.12722>
Stewart ZA and others, ‘Closed-Loop Insulin Delivery during Pregnancy in Women with Type 1 Diabetes’ (2016) 375 New England Journal of Medicine 644 <https://doi.org/10.1056/NEJMoa1602494>
Tanner M, ‘Review: In Type 2 Diabetes, Adding Dipeptidyl Peptidase-4 Inhibitors to Sulphonylureas Increases Hypoglycemia’ (2016) 165 Annals of Internal Medicine <https://doi.org/10.7326/ACPJC-2016-165-4-020>
Tao L and others, ‘Cost-Effectiveness of Intensive Multifactorial Treatment Compared with Routine Care for Individuals with Screen-Detected Type 2 Diabetes: Analysis of the ADDITION-UK Cluster-Randomized Controlled Trial’ (2015) 32 Diabetic Medicine 907 <https://doi.org/10.1111/dme.12711>
The Eatwell Guide (Public Health England 2016) <https://www.gov.uk/government/publications/the-eatwell-guide>
‘Type 2 Diabetes in Adults: Management | Guidance and Guidelines | NICE’ <https://www.nice.org.uk/guidance/ng28>
‘Type 2 Diabetes: Lixisenatide | Evidence-Review | Advice | NICE’ <https://www.nice.org.uk/advice/esnm26/chapter/evidence-review>
‘Type 2 Diabetes: Prevention in People at High Risk | Guidance and Guidelines | NICE’ <http://www.nice.org.uk/guidance/PH38>
Umpierre D, ‘Physical Activity Advice Only or Structured Exercise Training and Association With HbA Levels in Type 2 Diabetes’ (2011) 305 JAMA <https://doi.org/10.1001/jama.2011.576>
‘Unit 3 – Special Care Groups: A Practical Guide to Pregnancy Complicated by Diabetes - Diabetes & Primary Care’ <http://www.diabetesandprimarycare.co.uk/journal-content/view/unit-3-special-care-groups-a-practical-guide-to-pregnancy-complicated-by-diabetes/?preview>
Villani M, de Courten B and Zoungas S, ‘Emergency Treatment of Hypoglycaemia: A Guideline and Evidence Review’ (2017) 34 Diabetic Medicine 1205 <https://doi.org/10.1111/dme.13379>
Vloemans AF and others, ‘Keeping Safe. Continuous Glucose Monitoring (CGM) in Persons with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia: A Qualitative Study’ (2017) 34 Diabetic Medicine 1470 <https://doi.org/10.1111/dme.13429>
Wanner C and others, ‘Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes’ (2016) 375 New England Journal of Medicine 323 <https://doi.org/10.1056/NEJMoa1515920>
William H. Polonsky,Lawrence Fisher,Jay Earles,R. James Dudl,Joel Lees,Joseph Mullan, ‘Assessing Psychosocial Distress in Diabetes: Development of the Diabetes Distress Scale’ Diabetes Care <http://go.galegroup.com.ezproxy3.lib.le.ac.uk/ps/retrieve.do?tabID=T002&resultListType=RESULT_LIST&searchResultsType=SingleTab&searchType=AdvancedSearchForm&currentPosition=25&docId=GALE%7CA130282980&docType=Article&sort=Relevance&contentSegment=&prodId=EAIM&contentSet=GALE%7CA130282980&searchId=R15&userGroupName=leicester&inPS=true>
Yates T and Davies MJ, ‘Physical Activity and Type 1 Diabetes: An Underused Therapy’ (2017) 34 Diabetic Medicine 1498 <https://doi.org/10.1111/dme.13445>
Yeh JS, Kushner RF and Schiff GD, ‘Obesity and Management of Weight Loss’ (2016) 375 New England Journal of Medicine 1187 <https://doi.org/10.1056/NEJMclde1515935>
Young-Hyman D and others, ‘Erratum. Psychosocial Care for People With Diabetes: A Position Statement of the American Diabetes Association. Diabetes Care 2016;39:2126–2140’ (2017) 40 Diabetes Care 287.1 <https://doi.org/10.2337/dc17-er02>
Zaccardi F and others, ‘Pathophysiology of Type 1 and Type 2 Diabetes Mellitus: A 90-Year Perspective’ (2016) 92 Postgraduate Medical Journal 63 <https://doi.org/10.1136/postgradmedj-2015-133281>
